AstraZeneca Pharma India lost 4.17% to Rs 874.10 on BSE at 1027 hrs after the company reported a net loss of Rs 27.96 crore in Q2 September 2014, higher than net loss of Rs 1.23 crore in Q2 September 2013.
AstraZeneca Pharma India's net sales declined 0.9% to Rs 114.55 crore in Q2 September 2014 over Q2 September 2013.
The Q2 result was announced after market hours on Monday, 3 November 2014.
On BSE, so far 2,321 shares were traded in the counter as against average daily volume of 2,907 shares in the past one quarter.
The stock hit a high of Rs 902.60 and a low of Rs 868 so far during the day. The stock had hit a 52-week low of Rs 725.85 on 4 February 2014. The stock had hit a 52-week high of Rs 1,285 on 4 March 2014.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app